JP2006502229A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006502229A5 JP2006502229A5 JP2004543576A JP2004543576A JP2006502229A5 JP 2006502229 A5 JP2006502229 A5 JP 2006502229A5 JP 2004543576 A JP2004543576 A JP 2004543576A JP 2004543576 A JP2004543576 A JP 2004543576A JP 2006502229 A5 JP2006502229 A5 JP 2006502229A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- subunit
- fatty acid
- acid amide
- amide hydrolase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCC(CC)C1=N*(*)=C(*)*1 Chemical compound CCC(CC)C1=N*(*)=C(*)*1 0.000 description 32
- JZMJPQSSQDZJOZ-OUOSTHCTSA-N CC/C=C(/CC)\c1ncc(/C(/S)=N/C=C\C)[o]1 Chemical compound CC/C=C(/CC)\c1ncc(/C(/S)=N/C=C\C)[o]1 JZMJPQSSQDZJOZ-OUOSTHCTSA-N 0.000 description 2
- POTKLASIBLXGKX-UHFFFAOYSA-N CCC(C)Cc1nc(-c2cnc[o]2)c[o]1 Chemical compound CCC(C)Cc1nc(-c2cnc[o]2)c[o]1 POTKLASIBLXGKX-UHFFFAOYSA-N 0.000 description 2
- GZJXHVJMBUKZFU-BXIAMOKOSA-N CCC(CC)/C(/C)=N/C=C(/c1c[o]cc1)\O Chemical compound CCC(CC)/C(/C)=N/C=C(/c1c[o]cc1)\O GZJXHVJMBUKZFU-BXIAMOKOSA-N 0.000 description 2
- ULKQEZAYRDJPNB-UHFFFAOYSA-N CCC(c1ncc(-c2cnc[o]2)[o]1)=C=C Chemical compound CCC(c1ncc(-c2cnc[o]2)[o]1)=C=C ULKQEZAYRDJPNB-UHFFFAOYSA-N 0.000 description 2
- OXKIWEHCLSLLMB-UHFFFAOYSA-N CCC1(Cc2nc(-c3ncc[n]3C)c[o]2)CC1 Chemical compound CCC1(Cc2nc(-c3ncc[n]3C)c[o]2)CC1 OXKIWEHCLSLLMB-UHFFFAOYSA-N 0.000 description 2
- JUGSPWDXQAPNQS-UHFFFAOYSA-N CCCC(CC)c1nc(-c2ncc[s]2)c[o]1 Chemical compound CCCC(CC)c1nc(-c2ncc[s]2)c[o]1 JUGSPWDXQAPNQS-UHFFFAOYSA-N 0.000 description 2
- OBVXMVKBGRIVEZ-FPYGCLRLSA-N CC/C(/C1OC=C(c2c[o]c[n]2)N1)=C\C Chemical compound CC/C(/C1OC=C(c2c[o]c[n]2)N1)=C\C OBVXMVKBGRIVEZ-FPYGCLRLSA-N 0.000 description 1
- KCXNEKUJNQIGAM-UHFFFAOYSA-N CCC(C)Cc1nnc[o]1 Chemical compound CCC(C)Cc1nnc[o]1 KCXNEKUJNQIGAM-UHFFFAOYSA-N 0.000 description 1
- SHWQKESHXWDQMZ-UHFFFAOYSA-N CCC(CC)c1nc(C2=COCC2)c[o]1 Chemical compound CCC(CC)c1nc(C2=COCC2)c[o]1 SHWQKESHXWDQMZ-UHFFFAOYSA-N 0.000 description 1
- QKPUWAGWEQPXEL-UHFFFAOYSA-N CCC(CC)c1ncc(-c2ncccc2)[o]1 Chemical compound CCC(CC)c1ncc(-c2ncccc2)[o]1 QKPUWAGWEQPXEL-UHFFFAOYSA-N 0.000 description 1
- UMFBKIKEQZLXAX-UHFFFAOYSA-N CCCC(CC)c1nc(-c2c(C)[o]nc2)c[o]1 Chemical compound CCCC(CC)c1nc(-c2c(C)[o]nc2)c[o]1 UMFBKIKEQZLXAX-UHFFFAOYSA-N 0.000 description 1
- GZPCZBJRBBTEHN-UHFFFAOYSA-N CCCC(CC)c1nc(-c2nnc[o]2)c[o]1 Chemical compound CCCC(CC)c1nc(-c2nnc[o]2)c[o]1 GZPCZBJRBBTEHN-UHFFFAOYSA-N 0.000 description 1
- ZLJXPOJIRREUFB-UHFFFAOYSA-N CCCC(CC)c1nc(Cc2c[n](C)cc2)c[o]1 Chemical compound CCCC(CC)c1nc(Cc2c[n](C)cc2)c[o]1 ZLJXPOJIRREUFB-UHFFFAOYSA-N 0.000 description 1
- ILOIOIGZFHGSMS-UHFFFAOYSA-N O=C(CCCCCCc1ccccc1)c1ncc(-c2ccccn2)[o]1 Chemical compound O=C(CCCCCCc1ccccc1)c1ncc(-c2ccccn2)[o]1 ILOIOIGZFHGSMS-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41724702P | 2002-10-08 | 2002-10-08 | |
| PCT/US2003/031975 WO2004033652A2 (en) | 2002-10-08 | 2003-10-08 | Inhibitors of fatty acid amide hydrolase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006502229A JP2006502229A (ja) | 2006-01-19 |
| JP2006502229A5 true JP2006502229A5 (https=) | 2010-09-09 |
| JP4628789B2 JP4628789B2 (ja) | 2011-02-09 |
Family
ID=32093990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004543576A Expired - Fee Related JP4628789B2 (ja) | 2002-10-08 | 2003-10-08 | 脂肪酸アミド加水分解酵素の阻害剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7662971B2 (https=) |
| EP (2) | EP2093220A3 (https=) |
| JP (1) | JP4628789B2 (https=) |
| KR (1) | KR20050070041A (https=) |
| CN (1) | CN1703407A (https=) |
| AT (1) | ATE431342T1 (https=) |
| AU (1) | AU2003275493A1 (https=) |
| BR (1) | BR0314980A (https=) |
| CA (1) | CA2501575A1 (https=) |
| DE (1) | DE60327640D1 (https=) |
| EA (1) | EA008767B1 (https=) |
| ES (1) | ES2325686T3 (https=) |
| MX (1) | MXPA05003762A (https=) |
| WO (1) | WO2004033652A2 (https=) |
| ZA (1) | ZA200501837B (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9597318B2 (en) | 2009-10-02 | 2017-03-21 | Avexxin As | 2-oxothiazole compounds and method of using same for chronic inflammatory disorders |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6462054B1 (en) | 2000-03-27 | 2002-10-08 | The Scripps Research Institute | Inhibitors of fatty acid amide hydrolase |
| BR0314980A (pt) | 2002-10-08 | 2005-08-09 | Scripps Research Inst | Inibidores de hidrolase de amida de ácido graxo |
| FR2865205B1 (fr) * | 2004-01-16 | 2006-02-24 | Sanofi Synthelabo | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique |
| FR2866886B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique |
| DE102004039326A1 (de) * | 2004-08-12 | 2006-02-16 | Abbott Gmbh & Co. Kg | Neue medizinische Verwendungen und Verfahren |
| US7351724B2 (en) | 2004-10-15 | 2008-04-01 | The Scripps Research Institute | Oxadiazole ketone inhibitors of fatty acid amide hydrolase |
| AR055831A1 (es) | 2004-12-30 | 2007-09-12 | Janssen Pharmaceutica Nv | Pepirazinilureas y piperidinilureas como moduladores de hidrolasa de amida de acidos grasos |
| PE20070099A1 (es) | 2005-06-30 | 2007-02-06 | Janssen Pharmaceutica Nv | N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso |
| EP1954137A4 (en) | 2005-11-18 | 2008-12-17 | Janssen Pharmaceutica Nv | 2-KETO-OXAZOLE AS MODULATORS OF FATTY ACID AMIDHYDROLASE |
| JP2009527483A (ja) | 2006-02-17 | 2009-07-30 | ザ・スクリプス・リサーチ・インステイチユート | 脂肪酸アミドヒドロラーゼの調節因子としてのオキサゾールケトン |
| WO2008013963A2 (en) | 2006-07-28 | 2008-01-31 | University Of Connecticut | Fatty acid amide hydrolase inhibitors |
| WO2008030532A2 (en) * | 2006-09-08 | 2008-03-13 | The Scripps Research Institute | Substituted oxazole ketone modulators of fatty acid amide hydrolase |
| AU2008257154B2 (en) * | 2007-05-25 | 2014-03-06 | The Scripps Research Institute | Tetracyclic inhibitors of fatty acid amide hydrolase |
| EP2161997A4 (en) * | 2007-05-31 | 2011-04-06 | Scripps Research Inst | TRICYCLIC INHIBITORS OF FATTY ACID AMIDHYDROLASE |
| CA2714743C (en) * | 2008-02-19 | 2017-01-17 | Janssen Pharmaceutica N.V. | Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
| US20110184026A1 (en) * | 2008-06-19 | 2011-07-28 | Boger Dale L | C4-substituted alpha-keto oxazoles |
| WO2010005572A2 (en) * | 2008-07-09 | 2010-01-14 | The Scripps Research Institute | Alpha-keto heterocycles as faah inhibitors |
| EP2321288B1 (en) | 2008-08-04 | 2014-03-19 | Merck Sharp & Dohme Corp. | Oxazole derivatives useful as inhibitors of faah |
| US8461159B2 (en) | 2008-11-25 | 2013-06-11 | Jannsen Pharmaceutica BV | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| US8598356B2 (en) | 2008-11-25 | 2013-12-03 | Janssen Pharmaceutica Nv | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| JP5657566B2 (ja) * | 2008-12-24 | 2015-01-21 | バイアル ポルテラ アンド シーエイ エス エイＢＩＡＬ−Ｐｏｒｔｅｌａ ＆ Ｃａ， Ｓ．Ａ． | 医薬品 |
| AR076687A1 (es) * | 2009-05-18 | 2011-06-29 | Infinity Pharmaceuticals Inc | Isoxazolinas como inhibidores de la amidahidrolasa de acidos grasos y com-posiciones farmaceuticas que los contienen |
| WO2010141809A1 (en) | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase |
| WO2010141817A1 (en) | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
| US8906914B2 (en) | 2009-08-18 | 2014-12-09 | Janssen Pharmaceutica Nv | Ethylene diamine modulators of fatty acid hydrolase |
| ES2626246T3 (es) | 2009-09-09 | 2017-07-24 | Sumitomo Dainippon Pharma Co., Ltd. | Derivado de 8-oxodihidropurina |
| US20120225097A1 (en) | 2009-11-12 | 2012-09-06 | Hawryluk Natalie A | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
| WO2011085216A2 (en) | 2010-01-08 | 2011-07-14 | Ironwood Pharmaceuticals, Inc. | Use of faah inhibitors for treating parkinson's disease and restless legs syndrome |
| BR112012018913A2 (pt) * | 2010-01-28 | 2017-06-20 | Merck Sharp & Dohme | "composição farmacêutica, e, uso da composição" |
| PT2544679T (pt) | 2010-03-12 | 2019-07-11 | Omeros Corp | Inibidores de pde-10 e composições e métodos relacionados |
| WO2011123719A2 (en) | 2010-03-31 | 2011-10-06 | Ironwood Pharmaceuticals, Inc. | Use of faah inhibitors for treating abdominal, visceral and pelvic pain |
| US9006433B2 (en) | 2010-04-21 | 2015-04-14 | Merck Sharp & Dohme Corp. | Substituted pyrimidines |
| UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
| ES2888231T3 (es) * | 2010-09-20 | 2022-01-03 | Sirna Therapeutics Inc | Lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos |
| CN102964311B (zh) * | 2011-09-01 | 2016-03-09 | 大丰海嘉诺药业有限公司 | 一种合成4-甲基-5-烷氧基噁唑的方法 |
| ES2648188T3 (es) * | 2012-02-17 | 2017-12-29 | Epitech Group S.P.A. | Composiciones y métodos para la modulación de amidasas específicas para N-aciletanolaminas para ser usadas en la terapia de enfermedades inflamatorias |
| CN105102438B (zh) | 2013-01-29 | 2019-04-30 | 埃维克辛公司 | 抗炎症和抗肿瘤的2-氧代噻唑类和2-氧代噻吩类化合物 |
| WO2015066277A1 (en) | 2013-11-01 | 2015-05-07 | Merial Limited | Antiparisitic and pesticidal isoxazoline compounds |
| NZ716494A (en) | 2014-04-28 | 2017-07-28 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
| NZ630803A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
| GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
| US20160244860A1 (en) * | 2015-02-20 | 2016-08-25 | Cytec Industries Inc. | Aliphatic-aromatic heterocyclic compounds and uses thereof in metal extractant compositions |
| US9879002B2 (en) | 2015-04-24 | 2018-01-30 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| EP3095787A1 (en) * | 2015-05-22 | 2016-11-23 | Universiteit Leiden | Pharmaceutically active compounds as dag-lipase inhibitors |
| US9920045B2 (en) | 2015-11-04 | 2018-03-20 | Omeros Corporation | Solid state forms of a PDE10 inhibitor |
| GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| JP7531351B2 (ja) | 2019-11-13 | 2024-08-09 | 東京エレクトロン株式会社 | 基板処理方法、基板処理装置、および基板処理システム |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA19269A1 (fr) * | 1980-09-16 | 1982-04-01 | Lilly Co Eli | Perfectionnement relatif a des derives de n-arylbenzamides . |
| US5646289A (en) * | 1994-10-24 | 1997-07-08 | Eli Lilly And Company | Heterocyclic compounds and their preparation and use |
| TW200404789A (en) * | 1999-03-15 | 2004-04-01 | Axys Pharm Inc | Novel compounds and compositions as protease inhibitors |
| US6462054B1 (en) | 2000-03-27 | 2002-10-08 | The Scripps Research Institute | Inhibitors of fatty acid amide hydrolase |
| US20020103192A1 (en) | 2000-10-26 | 2002-08-01 | Curtin Michael L. | Inhibitors of histone deacetylase |
| BR0314980A (pt) | 2002-10-08 | 2005-08-09 | Scripps Research Inst | Inibidores de hidrolase de amida de ácido graxo |
-
2003
- 2003-10-08 BR BR0314980-3A patent/BR0314980A/pt not_active IP Right Cessation
- 2003-10-08 ES ES03759771T patent/ES2325686T3/es not_active Expired - Lifetime
- 2003-10-08 EP EP09006391A patent/EP2093220A3/en not_active Withdrawn
- 2003-10-08 EA EA200500633A patent/EA008767B1/ru unknown
- 2003-10-08 DE DE60327640T patent/DE60327640D1/de not_active Expired - Lifetime
- 2003-10-08 WO PCT/US2003/031975 patent/WO2004033652A2/en not_active Ceased
- 2003-10-08 CA CA002501575A patent/CA2501575A1/en not_active Abandoned
- 2003-10-08 JP JP2004543576A patent/JP4628789B2/ja not_active Expired - Fee Related
- 2003-10-08 KR KR1020057006019A patent/KR20050070041A/ko not_active Withdrawn
- 2003-10-08 EP EP03759771A patent/EP1549624B1/en not_active Expired - Lifetime
- 2003-10-08 CN CNA2003801009944A patent/CN1703407A/zh active Pending
- 2003-10-08 US US10/528,552 patent/US7662971B2/en not_active Expired - Fee Related
- 2003-10-08 AT AT03759771T patent/ATE431342T1/de not_active IP Right Cessation
- 2003-10-08 AU AU2003275493A patent/AU2003275493A1/en not_active Abandoned
- 2003-10-08 MX MXPA05003762A patent/MXPA05003762A/es not_active Application Discontinuation
-
2005
- 2005-03-03 ZA ZA200501837A patent/ZA200501837B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9597318B2 (en) | 2009-10-02 | 2017-03-21 | Avexxin As | 2-oxothiazole compounds and method of using same for chronic inflammatory disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006502229A5 (https=) | ||
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| WO2005105732A8 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
| CY1111310T1 (el) | Ενωσεις για την αγωγη μεταβολικων διαταραχων | |
| EA201001455A1 (ru) | Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3) | |
| WO2003097598A8 (en) | Compound exhibiting pgd 2 receptor antagonism | |
| RU2011143741A (ru) | Производное индолизина и его применение в медицинских целях | |
| MY144209A (en) | Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors | |
| TW200508217A (en) | 2-cyanopropanoic acid amide and ester derivatives and methods of their use | |
| JP2012520247A5 (https=) | ||
| JP2010515731A5 (https=) | ||
| MX2010007977A (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica. | |
| WO2008126901A1 (ja) | 含窒素複素環化合物およびそれを含有する医薬組成物 | |
| EP1798226A4 (en) | TRAIZOL DERIVATIVE | |
| EA201290397A1 (ru) | 1,3,4-оксадиазол-2-карбоксамидное соединение | |
| WO2004020430A3 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
| MX2010007026A (es) | Derivados de triazoloxadiazoles. | |
| WO2008012782A3 (en) | Labelled analogues of halobenzamides as radiopharmaceuticals | |
| CA2722102A1 (en) | Phenylpropionic acid derivative and use thereof | |
| EP1106607A3 (en) | Uracil compounds and their use | |
| MY151228A (en) | Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same | |
| WO2008060787A3 (en) | Methods for treatment of cochlear and vestibular disorders | |
| WO2008122534A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| JP2008169366A5 (https=) |